Geeta Sharma, MD

Insurance Information

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Publications

Scopus h-index:9

Article:13

Review Article:2

Recent Artifacts

• Maternal and neonatal characteristics associated with neonatal neutropenia in hypertensive pregnancies
• Enhancing patient autonomy with risk assessment and invasive diagnosis: an ethical solution to a clinical challenge
• Ethical considerations of early (first vs. second trimester) risk assessment disclosure for trisomy 21 and patient choice in screening versus diagnostic testing
• Patient preference regarding first-trimester aneuploidy risk assessment
• Gestational age-specific distribution of twin birth weight discordance
• Ethical considerations in elective cesarean delivery
• The ponderal index in triplets: III. Association with birth weight discordance
• The ponderal index in triplets: I. Relationship to small for gestational age neonates
• The ponderal index in triplets: II. Gestational age-related patterns of neonatal weights and lengths
• Prognostic factors associated with antenatal subchorionic echolucencies

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Sharma did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.